Literature DB >> 32837567

Covid-19: high rates of severity and death in elderly and patients with chronic diseases reinforces the importance of regular physical activity.

Guilherme F Speretta1, Richard Diego Leite2.   

Abstract

Entities:  

Year:  2020        PMID: 32837567      PMCID: PMC7382704          DOI: 10.1007/s11332-020-00678-8

Source DB:  PubMed          Journal:  Sport Sci Health        ISSN: 1824-7490


× No keyword cloud information.
Coronavirus disease 2019 (Covid-19) caused by Coronavirus 2 (SARS-CoV-2) has been emerging exponentially worldwide with approximately 8,261,260 confirmed cases and 445,468 deaths up to Jun 17, 2020 [1]. Although in most cases the Covid-19 symptoms are mild, the SARS-CoV-2 is transmitted easily and quickly and can overwhelm health systems [2]. Current evidence indicated that at least 15% of Covid-19 patients develop severe symptoms and need intensive care [3-5]. Noticeably, age is a factor that contributes to severe outcomes [6] and the presence of chronic diseases (CDs), in patients at any age, seems to contribute to severity and death [5]. An Italian report has described the characteristics of Covid-19 associated deaths, showing that the mean age was 78.5 and the most common pre-existing comorbidities were hypertension and diabetes [5]. Furthermore, according to data from the China outbreak, hypertension and diabetes were more prevalent in Covid-19 patients with severe (23.6 and 16.8%, respectively) compared to those with nonsevere (13.3 and 5.7%) symptoms [3]. It is well accepted that increases in visceral adipose tissue lead to metabolic alterations and chronic inflammation, increasing the risk for CDs [7]. These disturbers also negatively impact immunity from infection, vaccine efficacy [8], and may contribute to the severity of Covid-19 since evidence suggests that a subgroup of those patients have a cytokine storm syndrome (i.e. hyperinflammation) [9]. Indeed, it has been demonstrated that obesity is a risk factor for Covid-19 intensive care admission in patients younger than 60 years in the United States [10]. A French study also showed that the risk for invasive mechanical ventilation among Covid-19 patients was 7.36 higher for those with body mass index (BMI) > 35 kg/m2 compared to patients with BMI < 25 kg/m2 [11]. No vaccines or specific drugs have been developed for Covid-19 to date. Furthermore, even countries that have adopted social isolation policies to mitigate or suppress the transmission may have a second wave of SARS-CoV-2 contamination [2]. Beyond social isolation, can behavioral interventions help to reduce Covid-19 morbidity and mortality? We believe that alterations of the contemporary lifestyle, that includes sedentarism, unhealthy food intake, and stress [7], would help to prevent severe outcomes in infected people. For instance, regular physical activity (PA) has been associated with benefits to the immune system in different populations [12, 13]. Regular PA seems to attenuate the immune disturbers related to age (i.e. immunosenescence), particularly preventing T cell remodelling. It reduces the risk of infections and improves the control of latent viral infection [12]. Higher PA levels also induce enhancements in the metabolism and the cardiovascular system in healthy individuals and people with CDs [14]. PA may induce short-term immune adaptations and it has been attributed to an anti-inflammatory effect by the visceral fat mass reduction and/or the induction of an anti-inflammatory environment [13]. It has been recommended that active people should maintain PA as part of their routine during the Covid-19 pandemic [15]. Nevertheless, it is still unclear whether the same applies to sedentary, elderly, and people with CDs. Studies have shown that excessive PA amount or intensity induces lymphocytosis during and immediately after exercise [13]. This may lead to a transitory immune depression, although the lymphocytes levels return to basal within 24 h [13]. On the other hand, short moderate-intensity activities seem to do not promote significant acute immune depression [13]. Thus, it seems to be safe to incorporate regular moderate doses of PA as part of the routine. The American College of Sports Medicine recommends ≥ 30 min of moderate PA on ≥ 5 days/week. However, performing ≥ 30 min of PA all at once could be exhausting for people with very low PA levels [14]. For this reason, breaking up the total time throughout the day should be considered [14]. The guidelines suggest that moderate exercise should be performed between 64–76% of maximal heart rate and/between 12–13 on the 6–20 rating of perceived exertion Borg´s Scale [14]. Importantly, in addition to immune and cardiometabolic positive effects, regular PA may protect against psychological distress [16] that has been described in different populations during the Covid-19 pandemic [17]. The Covid-19 outbreak is causing a very deleterious impact on the health and economic systems worldwide. Thus, we strongly suggest the development of studies to evaluate the impact of PA levels and other lifestyle factors on the severity and deaths in patients with Covid-19. We are aware that a healthy lifestyle, including PA, will not be the solution for the pandemic, nevertheless, it can be a valuable adjuvant acting as following. First, improving immunity, especially in elderly people, and the clinical condition of patients with CDs. Second, increasing the Covid-19 vaccine efficacy when it is available. Third, enhancing mental health. Taken together, the PA outcomes might also promote indirect effects such as less overwhelming of health systems by decreasing the number of severe cases, which also would result in significant economic benefits.
  14 in total

Review 1.  Position statement. Part one: Immune function and exercise.

Authors:  Neil P Walsh; Michael Gleeson; Roy J Shephard; Maree Gleeson; Jeffrey A Woods; Nicolette C Bishop; Monika Fleshner; Charlotte Green; Bente K Pedersen; Laurie Hoffman-Goetz; Connie J Rogers; Hinnak Northoff; Asghar Abbasi; Perikles Simon
Journal:  Exerc Immunol Rev       Date:  2011       Impact factor: 6.308

2.  Obesity in Patients Younger Than 60 Years Is a Risk Factor for COVID-19 Hospital Admission.

Authors:  Jennifer Lighter; Michael Phillips; Sarah Hochman; Stephanie Sterling; Diane Johnson; Fritz Francois; Anna Stachel
Journal:  Clin Infect Dis       Date:  2020-07-28       Impact factor: 9.079

3.  American College of Sports Medicine position stand. Quantity and quality of exercise for developing and maintaining cardiorespiratory, musculoskeletal, and neuromotor fitness in apparently healthy adults: guidance for prescribing exercise.

Authors:  Carol Ewing Garber; Bryan Blissmer; Michael R Deschenes; Barry A Franklin; Michael J Lamonte; I-Min Lee; David C Nieman; David P Swain
Journal:  Med Sci Sports Exerc       Date:  2011-07       Impact factor: 5.411

Review 4.  Abdominal obesity and metabolic syndrome.

Authors:  Jean-Pierre Després; Isabelle Lemieux
Journal:  Nature       Date:  2006-12-14       Impact factor: 49.962

5.  Estimates of the severity of coronavirus disease 2019: a model-based analysis.

Authors:  Robert Verity; Lucy C Okell; Ilaria Dorigatti; Peter Winskill; Charles Whittaker; Natsuko Imai; Gina Cuomo-Dannenburg; Hayley Thompson; Patrick G T Walker; Han Fu; Amy Dighe; Jamie T Griffin; Marc Baguelin; Sangeeta Bhatia; Adhiratha Boonyasiri; Anne Cori; Zulma Cucunubá; Rich FitzJohn; Katy Gaythorpe; Will Green; Arran Hamlet; Wes Hinsley; Daniel Laydon; Gemma Nedjati-Gilani; Steven Riley; Sabine van Elsland; Erik Volz; Haowei Wang; Yuanrong Wang; Xiaoyue Xi; Christl A Donnelly; Azra C Ghani; Neil M Ferguson
Journal:  Lancet Infect Dis       Date:  2020-03-30       Impact factor: 25.071

6.  The immediate mental health impacts of the COVID-19 pandemic among people with or without quarantine managements.

Authors:  Shen Zhu; Yue Wu; Chun-Yan Zhu; Wan-Chu Hong; Zhi-Xi Yu; Zhi-Ke Chen; Zhen-Lei Chen; De-Guo Jiang; Yong-Guang Wang
Journal:  Brain Behav Immun       Date:  2020-04-18       Impact factor: 7.217

7.  Clinical Characteristics of Coronavirus Disease 2019 in China.

Authors:  Wei-Jie Guan; Zheng-Yi Ni; Yu Hu; Wen-Hua Liang; Chun-Quan Ou; Jian-Xing He; Lei Liu; Hong Shan; Chun-Liang Lei; David S C Hui; Bin Du; Lan-Juan Li; Guang Zeng; Kwok-Yung Yuen; Ru-Chong Chen; Chun-Li Tang; Tao Wang; Ping-Yan Chen; Jie Xiang; Shi-Yue Li; Jin-Lin Wang; Zi-Jing Liang; Yi-Xiang Peng; Li Wei; Yong Liu; Ya-Hua Hu; Peng Peng; Jian-Ming Wang; Ji-Yang Liu; Zhong Chen; Gang Li; Zhi-Jian Zheng; Shao-Qin Qiu; Jie Luo; Chang-Jiang Ye; Shao-Yong Zhu; Nan-Shan Zhong
Journal:  N Engl J Med       Date:  2020-02-28       Impact factor: 91.245

8.  Coronavirus disease (COVID-19): The need to maintain regular physical activity while taking precautions

Authors:  Peijie Chen; Lijuan Mao; George P Nassis; Peter Harmer; Barbara E Ainsworth; Fuzhong Li
Journal:  J Sport Health Sci       Date:  2020-02-04       Impact factor: 7.179

9.  Regular Moderate- to Vigorous-Intensity Physical Activity Rather Than Walking Is Associated with Enhanced Cognitive Functions and Mental Health in Young Adults.

Authors:  Takumi Nakagawa; Ibuki Koan; Chong Chen; Toshio Matsubara; Kosuke Hagiwara; Huijie Lei; Masako Hirotsu; Hirotaka Yamagata; Shin Nakagawa
Journal:  Int J Environ Res Public Health       Date:  2020-01-18       Impact factor: 3.390

10.  High Prevalence of Obesity in Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) Requiring Invasive Mechanical Ventilation.

Authors:  Arthur Simonnet; Mikael Chetboun; Julien Poissy; Violeta Raverdy; Jerome Noulette; Alain Duhamel; Julien Labreuche; Daniel Mathieu; Francois Pattou; Merce Jourdain
Journal:  Obesity (Silver Spring)       Date:  2020-06-10       Impact factor: 9.298

View more
  1 in total

Review 1.  Physical Activity, Sedentary Behavior and Well-Being of Adults with Physical Disabilities and/or Chronic Diseases during the First Wave of the COVID-19 Pandemic: A Rapid Review.

Authors:  Diederik R de Boer; Femke Hoekstra; Kimberley I M Huetink; Trynke Hoekstra; Leonie A Krops; Florentina J Hettinga
Journal:  Int J Environ Res Public Health       Date:  2021-06-11       Impact factor: 3.390

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.